99mTc-Infliximab-scintigraphy for the demonstration of tumor necrosis factor alpha in patients with arthritis and arthropathy.

R.W. Ripp, Friedl Herman, A. Dunzinger, C. Spreizer, Peter Angelberger, W. Graninger

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	213
Number of pages	1
Journal	European Journal of Nuclear Medicine and Molecular Imaging
Volume	33
Publication status	Published - 2006

Research Field

@article{c20419d474e94f64abac265c6fe3f20f,

title = "99mTc-Infliximab-scintigraphy for the demonstration of tumor necrosis factor alpha in patients with arthritis and arthropathy.",

keywords = "Infliximab, Infliximab",

author = "R.W. Ripp and Friedl Herman and A. Dunzinger and C. Spreizer and Peter Angelberger and W. Graninger",

year = "2006",

language = "English",

volume = "33",

pages = "213",

journal = "European Journal of Nuclear Medicine and Molecular Imaging",

issn = "1619-7070",

publisher = "Springer Verlag",

}

TY - JOUR

T1 - 99mTc-Infliximab-scintigraphy for the demonstration of tumor necrosis factor alpha in patients with arthritis and arthropathy.

AU - Ripp, R.W.

AU - Herman, Friedl

AU - Dunzinger, A.

AU - Spreizer, C.

AU - Angelberger, Peter

AU - Graninger, W.

PY - 2006

Y1 - 2006

KW - Infliximab

M3 - Article

SN - 1619-7070

VL - 33

SP - 213

JO - European Journal of Nuclear Medicine and Molecular Imaging

JF - European Journal of Nuclear Medicine and Molecular Imaging

ER -